The France PLGA Market was valued at $4.8 Million in 2023 and projected to reach to $11.9 Million by 2028, representing a compound annual growth rate of 13.9%. France's PLGA market is poised for sustained expansion through 2028, supported by regulatory mandates favoring biodegradable materials and increasing pharmaceutical industry investment in sustainable drug delivery solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France's PLGA market reached $4.8 million in 2023 and is forecast to grow to $11.9 million by 2028, demonstrating a robust 13.9% CAGR driven by increased adoption in pharmaceutical and medical device applications.
Stringent European Union regulations on sustainable materials and circular economy directives are accelerating PLGA adoption in France, positioning the country as a compliance-driven market leader in biodegradable polymers.
Growing demand for biodegradable drug delivery systems and controlled-release formulations in French pharmaceutical manufacturing is a primary growth catalyst, supported by major research institutions and biotech clusters.
France represents a significant segment of the European PLGA market, with competitive advantages in R&D capabilities, established chemical manufacturing infrastructure, and proximity to key European pharmaceutical hubs.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | -PLGA 12:88 (Composition) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 16.8% from 2023 to 2028 |
| Largest Segment | HIGH LACTIC ACID GRADE (Composition) |
| Market Size Base Year (Billions) | ~USD 0.12 (2023) |
| Revenue Forecast (Billions) | ~USD 0.26 (2028) |
| Segments Covered | End-Use Industry, Composition, Application, Processibility |
4 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BIOTECH FIRMS | 0.84 | 0.95 | 1.07 | 1.29 | 1.48 | 1.71 | 1.82 | 1.94 | 12.6 |
| HEALTHCARE | 2.02 | 2.21 | 2.41 | 2.8 | 3.13 | 3.51 | 3.62 | 3.73 | 9.2 |
| MEDICAL INSTITUTIONS | 1.36 | 1.52 | 1.68 | 1.99 | 2.26 | 2.58 | 2.7 | 2.83 | 11 |
| NON-MEDICAL END-USE | 0.16 | 0.25 | 0.38 | 0.6 | 0.91 | 1.37 | 1.91 | 2.65 | 48.8 |
| OTHER END-USE INDUSTRIES | 0.39 | 0.53 | 0.66 | 0.86 | 1 | 1.1 | 1 | 0.73 | 9.4 |
| TOTAL | 4.78 | 5.46 | 6.21 | 7.54 | 8.78 | 10.28 | 11.05 | 11.88 | 13.9 |
France's PLGA market was valued at $4.8 million in 2023 and is expected to reach $11.9 million by 2028.
France's PLGA market is growing at a compound annual growth rate (CAGR) of 13.9% from 2023 to 2028.
PLGA demand in France is driven by EU sustainability regulations, pharmaceutical innovation, biocompatible medical device applications, and green chemistry initiatives.
PLGA is primarily used in France's pharmaceutical sector for drug delivery systems, medical device manufacturing, and healthcare applications requiring biodegradable polymers.
France is a significant European PLGA market with strong research capabilities, advanced manufacturing infrastructure, and supportive regulatory frameworks that position it as a regional innovation leader.
The study involved four major activities in estimating the market size of the PLGA market. Exhaustive secondary research was done to collect information on the market, the peer market, and the grandparent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources have been referred to for identifying and collecting information for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, certified publications, trade directories, articles from recognized authors, gold standard and silver standard websites, and databases. Secondary research has been used to obtain key information about the value chain of the industry, monetary chain of the market, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.
The PLGA market comprises several stakeholders in the value chain, which include manufacturers, and end users. Various primary sources from the supply and demand sides of the PLGA market have been interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include key opinion leaders in healthcare sector. The primary sources from the supply side include manufacturers, associations, and institutions involved in the PLGA industry. Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to composition, processibility, application, end-use industry, and region. Stakeholders from the demand side, such as CIOs, CTOs, and CSOs were interviewed to understand the buyer’s perspective on the suppliers, products, component providers, and their current usage of PLGA and outlook of their business, which will affect the overall market.
The breakdown of profiles of the primary interviewees is illustrated in the figure below:

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2023 available in the public domain, product portfolios, and geographical presence.
Other designations include consultants and sales, marketing, and procurement managers.
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches have been used to estimate and validate the size of the PLGA market.

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the total market size from the estimation process, the overall market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and sub-segments, the data triangulation and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size has been validated by using both the top-down and bottom-up approaches and primary interviews. Hence, for every data segment, there have been three sources—top-down approach, bottom-up approach, and expert interviews. The data was assumed correct when the values arrived from the three sources matched.
PLGA, a group of biodegradable polymers approved by the FDA, stands out for its robustness, excellent biocompatibility, and extensive research as carriers for drugs, proteins, and diverse macromolecules like DNA, RNA, and peptides. Its popularity in the realm of biodegradable polymers stems from its extensive clinical track record, advantageous degradation properties, and potential for prolonged drug release.
Along with the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all PLGA Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report